Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Gamida Cell Ltd (GMDA)

Gamida Cell Ltd (GMDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Gamida Cell Ltd 116 Huntington Avenue 7th Floor Boston MA 02116 USA

www.gamida-cell.com P: 617-892-9080

Description:

Gamida Cell Ltd. is a biopharmaceutical company. It focuses on developing cell therapies to cure cancer and rare and serious hematologic diseases. The company's product pipeline consists of NiCord and NAM-NK which are in clinical stage. It operates primarily in the United States, the European Union and internationally. Gamida Cell Ltd. is headquartered in Jerusalem, Israel.

Key Statistics

Overview:

Market Capitalization, $K 5,037
Enterprise Value, $K -41,513
Shares Outstanding, K 154,051
Annual Sales, $ 1,780 K
Annual Net Income, $ -63,000 K
Last Quarter Sales, $ 1,110 K
Last Quarter Net Income, $ -8,840 K
EBIT, $ -73,040 K
EBITDA, $ -71,020 K
60-Month Beta 0.93
% of Insider Shareholders 3.40%
% of Institutional Shareholders 50.34%
Float, K 148,813
% Float 96.60%
Short Volume Ratio 0.55

Growth:

1-Year Return -95.76%
3-Year Return -99.58%
5-Year Return -99.64%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 94.59%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.04 on 03/27/24
Next Earnings Date 05/20/24
Earnings Per Share ttm -0.63
EPS Growth vs. Prev Qtr -300.00%
EPS Growth vs. Prev Year 86.21%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GMDA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -57.59%
Profit Margin % -3,539.33%
Debt/Equity 0.00
Price/Sales 3.45
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.03
Interest Coverage -7.27
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar